2024年12月20日 · Each year, about 1% of people with MGUS get certain types of blood cancers or other serious diseases, such as: Multiple myeloma. Light chain amyloidosis. Waldenstrom …

2019年8月13日 · A new study suggests that a person’s risk of progressing from a benign condition called monoclonal gammopathy of undetermined significance (MGUS) to multiple …

2022年7月25日 · Monoclonal gammopathy of undetermined significance (MGUS) is a blood disorder that affects plasma cells in your bone marrow. Most of the time, M proteins don’t …

MGUS is the first stage of myeloma before symptoms are present. It's a benign precursor to multiple myeloma, and patients with MGUS may or may never develop active myeloma.

It's not cancer. However, people with MGUS may have a greater risk of getting serious diseases of the bone marrow and blood. What causes monoclonal gammopathies? The exact cause of …

2022年7月13日 · MGUS usually doesn’t cause problems or need treatment. But in rare cases – 1% to 2% of the time – it can turn into the blood cancer multiple myeloma. If you have MGUS, …

MGUS is not classified as a cancer, but rather a pre-malignant condition, meaning an individual with MGUS may eventually develop a plasma cell disorder such as multiple myeloma or …

2018年1月11日 · Monoclonal gammopathy of undetermined significance (MGUS) is, in many ways, a unique hematologic entity. Unlike most hematologic conditions in which the diagnosis …

MGUS is a condition in which abnormal plasma cells produce too much M protein in the blood. It is often found during routine blood tests. It is not. cancer. When MGUS turns into myeloma, …

Each year, about 1 out of 100 people with MGUS (1%) develop a related cancer, such as myeloma or lymphoma. However, most people with MGUS never develop a related cancer …